Clinical Trial Update: Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update shows ABBV-400 alone or with bevacizumab being studied in adults with advanced solid tumors, including non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastroesophageal Adenocarcinoma
• Non-small Cell Lung Cancer
• Solid Tumors

Drugs mentioned

• ABBV-400
• Bevacizumab (bevacizumab)

Snippet

Sponsor: AbbVie | Conditions: Non-Small Cell Lung Cancer, Advanced Solid Tumors | Phase 1 | Status: ACTIVE_NOT_RECRUITING